| Code | 7921D | ||||||||||
| MA number | 29/0183/21-S | ||||||||||
| Product Form: | gél 1x100 g (tuba Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| Therapeutic Class: | 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 30 | ||||||||||
| Container: | tube Al | ||||||||||
| Route of admin.: | Cutaneous use |
| Prescription Status: | Medicinal product not subject to medical prescription. |
| Legal basis: | Article 10a well-established use application |
| MA issued: | 11.07.2021 |
| Validity: | 11.07.2026 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric warnings: | Yes |
| SPC: |
SPC_Ibuprofen Dr.Max 50 mg-g gél_04.2024.pdf
|
| PIL: |
PIL_Ibuprofen Dr.Max 50 mg-g gél_04.2024.pdf
|
| Safety feature | No |
| Data update: | 12.07.2021 |
